MedPath

APRESOLINE

APRESOLINE

Dormant
DIN Number

00723754

Drug Class

Human

Market Date

Dec 31, 1992

Company
HC

Sterimax Inc

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00723754
AIG Number0107444005
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C02DB02 HYDRALAZINE
Product Specifications
Dosage FormSolution
Route of AdministrationIntravenous
AHFS Classification24:08.20
Health Canada Classification

ACTIVE INGREDIENTS (1)

HYDRALAZINE HYDROCHLORIDEActive
Strength: 20 MG / ML
Monograph: HYDRALAZINE HYDROCHLORIDE

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.